Galaxy Today, Yuhong Medicine (688176.SH) announced that as of September 30, 2024, the company has repurchased a total of 8,351,322 shares, accounting for 1.4651% of the total share capital. The highest purchase price was RMB 6.73 per share, the lowest price was RMB 4.99 per share, and the total amount paid was RMB 47.787 million (excluding stamp duty, transaction commission, and other transaction costs).
- Headlines
- Yaohong Pharmaceuticals (688176.SH): has repurchased 1.4651% of the shares accumulated.
亚虹医药(688176.SH)：已累计回购1.4651%股份
Yaohong Pharmaceuticals (688176.SH): has repurchased 1.4651% of the shares accumulated.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
11:01
The Shanghai Composite Index fell to 3,200 points, down 0.94% for the day.
SSE Composite Index-0.75%
11:01
The Hang Seng Index fell by 1% to 19,252.67 points.
Hang Seng Index-1.12%
11:00
Merck's Gardasil has become the first and currently the only HPV vaccine approved for use in males in China.
MRK+1.30%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.